ETFsXtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF 1C
Xtrackers

Xtrackers II Target Maturity Sept 2031 EUR Corporate Bond UCITS ETF 1C

XM31 XETRAAccumulatingLuxembourg
Last close · EUR
9.88EUR
-0.10% · -€0.01
Published closes: 4 Nov 2026 - 5 Nov 2026
5 Nov 2026, close
XM31Base
Fund charges
Not publishedFee basis unverified
Fund size
Not published
Return 1Y
-0.5%
Sharpe 3Y
Not published
Volatility 1Y
3.3%annualised
Holdings
359Fund holdings

Performance

Compare
  • XM31-0.5%
  • Price, EUR

Returns

Returns1M3M6MYTD1Y3Y5Y
XM31+1.0%-1.0%0.0%-0.2%-0.5%--
MSCI World-2.8%-0.6%+7.8%+14.0%+14.1%+65.6%+64.8%
Gap to MSCI World+3.9%-0.4%-7.8%-14.2%-14.6%--

Risk and return

Sharpe ratio · 1Y
-0.94
Below MSCI World · 1.28
Return p.a.
-1.1%
Volatility
3.3%
Max loss
-3.2%Sept 2026

Sharpe vs indices

MSCI World
1.28
S&P 500
1.16
STOXX Europe 600
0.99
MSCI Emerging Markets IMI
0.76
CAC 40
-0.01
XM31
-0.94
Method

Weekly EUR returns from adjusted closes. Sharpe is the annualised excess return over the euro overnight rate (Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C) divided by its volatility. Max loss uses daily closes.

Top holdings

Top 10
6.1%
Holdings
359
As of
Fund holdings
  1. 1DH EUROPE FINANCE II SARLXS20504060940.69%
  2. 2THERMO FISHER SCIENTIFIC (FINAN)XS23664070180.69%
  3. 3INTESA SANPAOLO SPAXS26738087260.67%
  4. 4CREDIT AGRICOLE SAFR001400HCR40.63%
  5. 5TAKEDA PHARMACEUTICAL CO LTDXS18434493950.62%
  6. 6ING GROEP NVXS19091864510.60%
  7. 7VERIZON COMMUNICATIONS INCXS25508811430.55%
  8. 8INTERNATIONAL BUSINESS MACHINES COXS25837422390.54%
  9. 9BANCO BILBAO VIZCAYA ARGENTARIA SAXS34291403980.54%
  10. 10STELLANTIS NVXS26346901140.54%

Countries

Classified 100.0%
Largest
25.7%United States
Top 3
57.6%
Effective number
7.41 / HHI

Market cap

Weight vs holdings

6.1%of the fund sits in the top 10 holdings
  • Holdings 1-10
  • Holdings 11-50
  • Holdings 51-200
  • Holdings 201+

Size split

Not published

Compare ETFs in Copio.

ETF comparison in the Copio app, showing costs and returns with illustrative data.

Factual research, without a suitability score or investment recommendation. Past relationships can change.